June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
HC-HA/PTX3, an active matrix component of amniotic membrane, inhibits proliferation and epithelial mesenchymal transition of RPE cells: a potential novel therapy for PVR
Author Affiliations & Notes
  • Ajay E Kuriyan
    Bascom Palmer Eye Institute, Univ of Miami/Miller School of Medicine, Miami, FL
  • Hua He
    TissueTech, Inc., Ocular Surface Center, and Ocular Surface Research Education Foundation, Miami, FL
  • Esdras Arrieta
    Bascom Palmer Eye Institute, Univ of Miami/Miller School of Medicine, Miami, FL
  • Varona Sargent
    Bascom Palmer Eye Institute, Univ of Miami/Miller School of Medicine, Miami, FL
  • Ying-Ting Zhu
    TissueTech, Inc., Ocular Surface Center, and Ocular Surface Research Education Foundation, Miami, FL
  • Chen-Wei Su
    TissueTech, Inc., Ocular Surface Center, and Ocular Surface Research Education Foundation, Miami, FL
  • Nidhi Batra
    Bascom Palmer Eye Institute, Univ of Miami/Miller School of Medicine, Miami, FL
  • Harry W Flynn
    Bascom Palmer Eye Institute, Univ of Miami/Miller School of Medicine, Miami, FL
  • Jean-Marie A Parel
    Bascom Palmer Eye Institute, Univ of Miami/Miller School of Medicine, Miami, FL
  • Scheffer C G Tseng
    TissueTech, Inc., Ocular Surface Center, and Ocular Surface Research Education Foundation, Miami, FL
  • Footnotes
    Commercial Relationships Ajay Kuriyan, Bayer (F); Hua He, Tissue Tech (E); Esdras Arrieta, None; Varona Sargent, None; Ying-Ting Zhu, Tissue Tech (E); Chen-Wei Su, Tissue Tech (E); Nidhi Batra, None; Harry Flynn, None; Jean-Marie Parel, None; Scheffer Tseng, Tissue Tech (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2287. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ajay E Kuriyan, Hua He, Esdras Arrieta, Varona Sargent, Ying-Ting Zhu, Chen-Wei Su, Nidhi Batra, Harry W Flynn, Jean-Marie A Parel, Scheffer C G Tseng; HC-HA/PTX3, an active matrix component of amniotic membrane, inhibits proliferation and epithelial mesenchymal transition of RPE cells: a potential novel therapy for PVR. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2287. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Proliferative vitreoretinopathy (PVR), characterized by retinal surface membranes, is the main cause of failure of rhegmatogenous retinal detachments (RRDs). We and others have reported that PVR is mediated by proliferation and epithelial mesenchymal transition (EMT) of RPE cells under the influence of vitreous growth factors. We have recently purified and characterized heavy chain-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) complex as a unique matrix component from amniotic membrane that exerts anti-inflammatory and anti-EMT effects. HC-HA/PTX3 can be solubilized and injected intravitreally. Therefore, we investigated whether HC-HA/PTX3 may inhibit RPE cell proliferation and EMT in vitro and established rabbit PVR model for future studies.

Methods: We first tested if 0.1 to 25 µg/ml HC-HA/PTX3 was toxic to ARPE-19 cells by the Cell Death ELISA in comparison to HA and PBS. We optimized proliferation of ARPE-19 cells measured by BrdU labeling (ELISA and immunofluorescence) regarding the cell density, culturing medium, serum starvation, and addition of different growth factors. EMT was induced by addition of TGFβ1 and measured by nuclear pSMAD2/3 staining. We assessed the inhibitory effect of HC-HA/PTX3 on proliferation and EMT in vitro. Additionally, two New Zealand white (NZW) rabbits underwent cryotherapy, gas displacement of vitreous with intravitreal perfluoron, gas-fluid exchange, and intravitreal injection of NZW RPE cells to induce PVR.

Results: There was no difference in ARPE-19 cell death by addition of HA-HA/PTX3 or HA, or PBS. EGF+FGF induced a 7-fold increase (p<0.05) in proliferation and EGF+FGF+TGFβ induced a 3-fold increase in nuclear pSMAD 2/3 staining. Addition of 25 µg/ml HC-HA/PTX3 inhibited EGF+FGF-induced proliferation 10-fold (p<0.05) and EGF+FGF+TGFβ-induced pSMAD 2/3 staining 2-fold (p<0.05). Addition of 25 µg/ml HA did not inhibit proliferation or nuclear pSMAD 2/3. Both rabbits developed open funnel RDs with PVR membranes four weeks after intravitreal injection of NZW rabbit RPE cells.

Conclusions: HC-HA/PTX3 is a non-toxic, potent inhibitor of RPE cell proliferation and EMT in vitro. We will further test whether intravitreal injection of HC-HA/PTX3 can inhibit PVR formation using the established rabbit model of PVR.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×